fda bpc-157 unapproved new drug warning letter to weigh easing limits on unproven peptides favored by RFK Jr Retatrutide, an experimental weight-loss drug,
Description
BPC-157 lyophilised research peptide in Australia, supplied for in-vitro laboratory investigation
Since no water is present, chemical reactions (e.g., hydrolysis) occur much more slowly
There is no legitimate generic or compounded version of either product
The body composition shift is the goal, not the number on the scale

Bahadir A, Reis PG, Erduran E